Blog

Results of a multi-center clinical trial for the treatment of idiopathic normal pressure hydrocephalus (iNPH) demonstrate that shunt surgery significantly improves gait and reduces falls in older adults with iNPH. This landmark study resolves decades of debate about whether shunts truly help patients. Learn more.

A patient must receive essential treatment for a brain tumor, even during an evacuation warning for the raging Pacific Palisades fire in 2025.

The third Wednesday of each July is Glioblastoma Awareness Day. Glioblastoma (GBM) is a complex and invasive form of brain cancer, presenting difficulties in its treatment. Learn more about GMB, clinical trials and the Cancer Moonshot.

Clinical trials are research studies that play a critical role in the advancement of clinical and medical knowledge about disease. At Pacific Neuroscience Institute (PNI), there are a number of upcoming and ongoing trials for patients with various neurological conditions.

Alzheimer’s disease is the leading cause of disability in people older than 65. The PREVENTION Trial from Providence and the Pacific Brain Health Center looks at whether healthy lifestyle changes combined with brain exercises can help prevent Alzheimer’s disease

Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.

Pacific Neuroscience Institute’s Pacific Brain Health Center, an outpatient clinic of the Providence Saint John’s Health Center in Santa Monica, CA, is the site for an IRB approved study from Evoke Neuroscience.

An antiviral and an anti-inflammatory therapy against COVID-19, and convalescent plasma are currently in clinical trials at Providence Saint John’s Health Center in Santa Monica, CA.

A new trial treatment using blood plasma donations from people who have fully recovered from COVID-19 infection may be helpful in treating other patients with COVID-19.

First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John’s Health Center Using Stemedica Ischemia-Tolerant Allogeneic Mesenchymal Bone Marrow Cells Published: Apr 20, 2020 Originally published: https://www.biospace.com/article/releases/first-covid-19-patient-treated-under-emergency-use-ind-at-providence-saint-john-s-health-center-using-stemedica-ischemia-tolerant-allogeneic-mesenchymal-bone-marrow-cells/ SANTA MONICA, Calif., April 20, 2020 /PRNewswire/ — A single patient, emergency Investigational New Drug (IND) use was...